These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 34696460)

  • 21. A Transcription Regulatory Sequence in the 5' Untranslated Region of SARS-CoV-2 Is Vital for Virus Replication with an Altered Evolutionary Pattern against Human Inhibitory MicroRNAs.
    Mohammadi-Dehcheshmeh M; Moghbeli SM; Rahimirad S; Alanazi IO; Shehri ZSA; Ebrahimie E
    Cells; 2021 Feb; 10(2):. PubMed ID: 33557205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2.
    Sauvat A; Ciccosanti F; Colavita F; Di Rienzo M; Castilletti C; Capobianchi MR; Kepp O; Zitvogel L; Fimia GM; Piacentini M; Kroemer G
    Cell Death Dis; 2020 Aug; 11(8):656. PubMed ID: 32814759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The highly conserved 5' untranslated region as an effective target towards the inhibition of Enterovirus 71 replication by unmodified and appropriate 2'-modified siRNAs.
    Deng JX; Nie XJ; Lei YF; Ma CF; Xu DL; Li B; Xu ZK; Zhang GC
    J Biomed Sci; 2012 Aug; 19(1):73. PubMed ID: 22889374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo.
    Müller C; Obermann W; Karl N; Wendel HG; Taroncher-Oldenburg G; Pleschka S; Hartmann RK; Grünweller A; Ziebuhr J
    Antiviral Res; 2021 Feb; 186():105012. PubMed ID: 33422611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AGO CLIP-based imputation of potent siRNA sequences targeting SARS-CoV-2 with antifibrotic miRNA-like activity.
    Ahn SH; Gu D; Koh Y; Lee HS; Chi SW
    Sci Rep; 2021 Sep; 11(1):19161. PubMed ID: 34580386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-scale CRISPR screens identify host factors that promote human coronavirus infection.
    Grodzki M; Bluhm AP; Schaefer M; Tagmount A; Russo M; Sobh A; Rafiee R; Vulpe CD; Karst SM; Norris MH
    Genome Med; 2022 Jan; 14(1):10. PubMed ID: 35086559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing.
    He X; Quan S; Xu M; Rodriguez S; Goh SL; Wei J; Fridman A; Koeplinger KA; Carroll SS; Grobler JA; Espeseth AS; Olsen DB; Hazuda DJ; Wang D
    Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33766889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.
    de Wilde AH; Wannee KF; Scholte FE; Goeman JJ; Ten Dijke P; Snijder EJ; Kikkert M; van Hemert MJ
    J Virol; 2015 Aug; 89(16):8318-33. PubMed ID: 26041291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemin as a novel candidate for treating COVID-19 via heme oxygenase-1 induction.
    Kim DH; Ahn HS; Go HJ; Kim DY; Kim JH; Lee JB; Park SY; Song CS; Lee SW; Ha SD; Choi C; Choi IS
    Sci Rep; 2021 Nov; 11(1):21462. PubMed ID: 34728736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication.
    Garcia G; Sharma A; Ramaiah A; Sen C; Purkayastha A; Kohn DB; Parcells MS; Beck S; Kim H; Bakowski MA; Kirkpatrick MG; Riva L; Wolff KC; Han B; Yuen C; Ulmert D; Purbey PK; Scumpia P; Beutler N; Rogers TF; Chatterjee AK; Gabriel G; Bartenschlager R; Gomperts B; Svendsen CN; Betz UAK; Damoiseaux RD; Arumugaswami V
    Cell Rep; 2021 Apr; 35(1):108940. PubMed ID: 33784499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.
    Fareh M; Zhao W; Hu W; Casan JML; Kumar A; Symons J; Zerbato JM; Fong D; Voskoboinik I; Ekert PG; Rudraraju R; Purcell DFJ; Lewin SR; Trapani JA
    Nat Commun; 2021 Jul; 12(1):4270. PubMed ID: 34257311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of SARS-CoV replication cycle by small interference RNAs silencing specific SARS proteins, 7a/7b, 3a/3b and S.
    Akerström S; Mirazimi A; Tan YJ
    Antiviral Res; 2007 Mar; 73(3):219-27. PubMed ID: 17112601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease.
    van de Sand L; Bormann M; Alt M; Schipper L; Heilingloh CS; Steinmann E; Todt D; Dittmer U; Elsner C; Witzke O; Krawczyk A
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33918301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of SARS-CoV-2 Replication with Stabilized and Click-Chemistry Modified siRNAs.
    Traube FR; Stern M; Tölke AJ; Rudelius M; Mejías-Pérez E; Raddaoui N; Kümmerer BM; Douat C; Streshnev F; Albanese M; Wratil PR; Gärtner YV; Nainytė M; Giorgio G; Michalakis S; Schneider S; Streeck H; Müller M; Keppler OT; Carell T
    Angew Chem Int Ed Engl; 2022 Sep; 61(38):e202204556. PubMed ID: 35802496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting sgRNA N secondary structure as a way of inhibiting SARS-CoV-2 replication.
    Baliga-Gil A; Soszynska-Jozwiak M; Ruszkowska A; Szczesniak I; Kierzek R; Ciechanowska M; Trybus M; Jackowiak P; Peterson JM; Moss WN; Kierzek E
    Antiviral Res; 2024 Aug; 228():105946. PubMed ID: 38925369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Supramolecular Cylinders Target Bulge Structures in the 5' UTR of the RNA Genome of SARS-CoV-2 and Inhibit Viral Replication*.
    Melidis L; Hill HJ; Coltman NJ; Davies SP; Winczura K; Chauhan T; Craig JS; Garai A; Hooper CAJ; Egan RT; McKeating JA; Hodges NJ; Stamataki Z; Grzechnik P; Hannon MJ
    Angew Chem Int Ed Engl; 2021 Aug; 60(33):18144-18151. PubMed ID: 33915014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A computational approach to design potential siRNA molecules as a prospective tool for silencing nucleocapsid phosphoprotein and surface glycoprotein gene of SARS-CoV-2.
    Chowdhury UF; Sharif Shohan MU; Hoque KI; Beg MA; Sharif Siam MK; Moni MA
    Genomics; 2021 Jan; 113(1 Pt 1):331-343. PubMed ID: 33321203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection.
    Humphries F; Shmuel-Galia L; Jiang Z; Wilson R; Landis P; Ng SL; Parsi KM; Maehr R; Cruz J; Morales-Ramos A; Ramanjulu JM; Bertin J; Pesiridis GS; Fitzgerald KA
    Sci Immunol; 2021 May; 6(59):. PubMed ID: 34010139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eight-amino-acid sequence at the N-terminus of SARS-CoV-2 nsp1 is involved in stabilizing viral genome replication.
    Ueno S; Amarbayasgalan S; Sugiura Y; Takahashi T; Shimizu K; Nakagawa K; Kawabata-Iwakawa R; Kamitani W
    Virology; 2024 Jul; 595():110068. PubMed ID: 38593595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.